After treating terminally ill patients with an unauthorized experimental probiotic procedure, two California doctors can no longer participated in human research.
Advertisement
The Scientist
Most Recent
The federal agency's surveillance of staffers feared to be leaking confidential information about medical devices was wider than previously thought.
Chemists are already finding ways to circumvent a new federal law cracking down on marijuana and methamphetamine mimics.
The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.
The maker of a pregnancy medication takes action against the federal agency for not stopping pharmacies from making and selling cheaper versions of the drug.
Present in every tissue of the body, ubiquitin appears to be involved in a dizzying array of functions, from cell cycle and division to organelle and ribosome biogenesis, as well as the response to viral infection. The protein plays at least two role
The placebo effect in clinical trials of the mental disorder has increased over the past decade.
Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.
Industry experts discuss the agency’s plans to make the drug approval process more transparent.
More than half of pharmaceutical companies on Twitter use more than one handle.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
